Developer docs
API playgroundTry for free, no card

Search company profiles

Vertos Medical

Full company profile

uuid00025s2

Namestring
Vertos Medical
Legal namestring
Vertos Medical Inc.
Websiteurl
vertosmed.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Vertos Medical, founded in 2005 and headquartered in Aliso Viejo, California, is a privately held medical device company specializing in minimally invasive treatments for lumbar spinal stenosis (LSS) and chronic low back pain. The company's core product is the mild® Procedure/System, a proprietary minimally invasive outpatient approach that removes small portions of bone and excess ligament tissue to relieve nerve compression in the lumbar spine and restore space in the spinal canal without significantly altering the structural anatomy. As of mid-2023, the mild® Procedure had been used to treat more than 70,000 patients in the United States, with reported clinical outcomes including an increase in average walking distance from 246 to 3,956 feet over one year post-procedure. Vertos holds a registered trademark on the mild® brand and operates within a focused single-indication portfolio.

Vertos generates revenue through hardware sales of the mild® device system to healthcare facilities — including hospitals, ambulatory surgery centers, and spine specialty clinics — using a direct enterprise field sales motion targeting physicians, pain management specialists, and spine surgeons. Pricing is established through standard healthcare procurement processes and is not publicly disclosed. Commercial adoption is supported by medical education, physician training programs, and industry conference participation. The company's customer base is segmented horizontally across the US healthcare provider landscape, with no single customer accounting for a disclosed share of revenue, and the company operates exclusively in the United States market with 101–250 employees.

The company has sustained venture-backed funding across 14 disclosed rounds from 2006 through 2023, with total disclosed capital raised exceeding $170 million. In June 2023, Vertos closed a $26 million oversubscribed Series C funding round led by Norwest Venture Partners with participation from Partner Ventures and Pitango VC, alongside a concurrent SEC-registered exempt securities offering of approximately $45.56 million. Earlier backers include MVM Life Science Partners, ONSET Ventures, CHL Medical Partners, DFJ Mercury, Foundation Capital, and Leerink Revelation Partners. In 2023, Vertos was recognized on the Deloitte Technology Fast 500 list, indicating rapid multi-year revenue growth as recognized by an external validator.

Short descriptiontext

Vertos Medical is a US medical device company that develops and commercializes the mild® Procedure, a minimally invasive outpatient treatment for lumbar spinal stenosis. The company sells its devices directly to hospitals, ambulatory surgery centers, and spine specialty clinics nationwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAliso Viejo, United States
HQ citystring
Aliso Viejo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
minimally invasive spine devices, lumbar spinal stenosis treatment, outpatient spine procedures, medical device manufacturing, spinal decompression devices
Industry2 codes
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKALAM
Pain Management (Spine & Musculoskeletal)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Minimally Invasive Spine Medical Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales - mild® Procedure
TypeHardware Sales
Description

Revenue generated from the sale of medical devices and procedures for treating lumbar spinal stenosis and chronic low back pain. The company has demonstrated rapid revenue growth with over 70,000 patients treated in the U.S.

prnewswire.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1mild®
Description

Minimally invasive device and procedure for treating lumbar spinal stenosis (LSS) used in outpatient procedures that remove small portions of bone and ligament to relieve nerve compression.

ow.ly
Core offering1 text field

Vertos Medical develops and markets the mild® System, a set of minimally invasive medical instruments used to perform the mild® Procedure for treating lumbar spinal stenosis (LSS). The procedure removes small portions of bone and ligament tissue through a small incision to relieve nerve pressure, and is typically delivered by pain management physicians or spine specialists in outpatient settings such as ambulatory surgery centers and office-based labs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 70,000 patients treated in the United States
+1 more record
Product overview1 text field

Vertos Medical offers a focused portfolio of minimally invasive spine treatment solutions centered on its flagship mild® System and mild® Procedure. The company specializes in treating lumbar spinal stenosis (LSS) and chronic low back pain through outpatient procedures that remove small portions of bone and ligament to relieve nerve compression. The mild® Procedure has been used to treat over 70,000 patients in the United States.

Product and service1 record
1mild® System
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Diversified medtech major whose Interventional Spine division directly references the mild® procedure alongside vertebral augmentation and basivertebral nerve ablation products, making it the most directly comparable incumbent in Vertos's LSS and interventional pain space.

TypeBroad incumbent
Description

Acquired Vertiflex (Superion) to enter the LSS market and has a broader pain and neuromodulation portfolio, making it a key incumbent competing for the same physician customers and LSS patient population.

TypeDirect peer
Description

Developer of the Superion Indirect Decompression System, an interspinous spacer for moderate LSS—historically the most direct procedural alternative to mild® and now commercialized inside Boston Scientific.

TypeDirect peer
Description

Maker of the Intracept procedure for vertebrogenic (basivertebral nerve) pain, an outpatient minimally invasive therapy targeting a closely overlapping LSS-adjacent patient population and physician call point.

TypeBroad incumbent
Description

Global spine leader with a comprehensive portfolio of surgical and interventional spine products, competing for hospital and ASC budgets and serving the same pain management and spine surgeon customers as Vertos.

TypeBroad incumbent
Description

Spine-focused medtech (now combined with NuVasive) with a broad MIS and interventional spine portfolio, competing with Vertos for the same hospital and ambulatory surgery center customers.

TypeDirect peer
Description

Developer of minimally invasive spine devices (including the Minuteman and Liberty products) targeting outpatient treatment of spinal stenosis and adjacent indications—a direct procedural and channel competitor to Vertos.

TypeEmerging player
Description

Specialist in minimally invasive sacroiliac joint fusion (iFuse), competing for the same pain management and interventional spine call point with an outpatient, MIS profile analogous to mild®.

TypeBroad incumbent
Description

Spinal cord stimulation (Proclaim) and broader neuromodulation portfolio positioned as a downstream therapy for chronic low back and leg pain patients, often competing with or complementing mild® in the same treatment pathway.

TypeEmerging player
Description

Independent spine company focused on MIS and lateral approaches, competing with Vertos for surgeon mindshare and hospital/ASC accounts in the degenerative lumbar and LSS-adjacent segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds14 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vertos Medical

Minimally Invasive Spine Medical Devicesvertosmed.com

Vertos Medical is a US medical device company that develops and commercializes the mild® Procedure, a minimally invasive outpatient treatment for lumbar spinal stenosis. The company sells its devices directly to hospitals, ambulatory surgery centers, and spine specialty clinics nationwide.

What Vertos Medical does

Vertos Medical, founded in 2005 and headquartered in Aliso Viejo, California, is a privately held medical device company specializing in minimally invasive treatments for lumbar spinal stenosis (LSS) and chronic low back pain. The company's core product is the mild® Procedure/System, a proprietary minimally invasive outpatient approach that removes small portions of bone and excess ligament tissue to relieve nerve compression in the lumbar spine and restore space in the spinal canal without significantly altering the structural anatomy. As of mid-2023, the mild® Procedure had been used to treat more than 70,000 patients in the United States, with reported clinical outcomes including an increase in average walking distance from 246 to 3,956 feet over one year post-procedure. Vertos holds a registered trademark on the mild® brand and operates within a focused single-indication portfolio.

Vertos generates revenue through hardware sales of the mild® device system to healthcare facilities — including hospitals, ambulatory surgery centers, and spine specialty clinics — using a direct enterprise field sales motion targeting physicians, pain management specialists, and spine surgeons. Pricing is established through standard healthcare procurement processes and is not publicly disclosed. Commercial adoption is supported by medical education, physician training programs, and industry conference participation. The company's customer base is segmented horizontally across the US healthcare provider landscape, with no single customer accounting for a disclosed share of revenue, and the company operates exclusively in the United States market with 101–250 employees.

The company has sustained venture-backed funding across 14 disclosed rounds from 2006 through 2023, with total disclosed capital raised exceeding $170 million. In June 2023, Vertos closed a $26 million oversubscribed Series C funding round led by Norwest Venture Partners with participation from Partner Ventures and Pitango VC, alongside a concurrent SEC-registered exempt securities offering of approximately $45.56 million. Earlier backers include MVM Life Science Partners, ONSET Ventures, CHL Medical Partners, DFJ Mercury, Foundation Capital, and Leerink Revelation Partners. In 2023, Vertos was recognized on the Deloitte Technology Fast 500 list, indicating rapid multi-year revenue growth as recognized by an external validator.

Vertos Medical firmographics

Firmographics
Name
Vertos Medical
Legal name
Vertos Medical Inc.
Website
https://vertosmed.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
Vertos Medical is a US medical device company that develops and commercializes the mild® Procedure, a minimally invasive outpatient treatment for lumbar spinal stenosis. The company sells its devices directly to hospitals, ambulatory surgery centers, and spine specialty clinics nationwide.
Ownership category
akta.pro rank

Vertos Medical industry classification

Industry
Product category
Minimally Invasive Spine Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKALAM
Pain Management (Spine & Musculoskeletal)

Keywords

  • Minimally invasive spine devices
  • Lumbar spinal stenosis treatment
  • Outpatient spine procedures
  • Medical device manufacturing
  • Spinal decompression devices

Where Vertos Medical is headquartered

Location

Headquarters

HQ city
Aliso Viejo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Vertos Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Sales - mild® Procedure: Revenue generated from the sale of medical devices and procedures for treating lumbar spinal stenosis and chronic low back pain. The company has demonstrated rapid revenue growth with over 70,000 patients treated in the U.S.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Vertos Medical product offering

Product offering

Core offering

Vertos Medical develops and markets the mild® System, a set of minimally invasive medical instruments used to perform the mild® Procedure for treating lumbar spinal stenosis (LSS). The procedure removes small portions of bone and ligament tissue through a small incision to relieve nerve pressure, and is typically delivered by pain management physicians or spine specialists in outpatient settings such as ambulatory surgery centers and office-based labs.

Product overview

Vertos Medical offers a focused portfolio of minimally invasive spine treatment solutions centered on its flagship mild® System and mild® Procedure. The company specializes in treating lumbar spinal stenosis (LSS) and chronic low back pain through outpatient procedures that remove small portions of bone and ligament to relieve nerve compression. The mild® Procedure has been used to treat over 70,000 patients in the United States.

Differentiator

Problem solved

Functional benefit

Brands

  • mild®: Minimally invasive device and procedure for treating lumbar spinal stenosis (LSS) used in outpatient procedures that remove small portions of bone and ligament to relieve nerve compression.

Products and services

  • mild® System

Quantifiable outcome

  • Over 70,000 patients treated in the United States
  • +1 more outcomes

Companies that use Vertos Medical

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Vertos Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Vertos Medical partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves3 records

Expansion highlights4 records

Vertos Medical competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Diversified medtech major whose Interventional Spine division directly references the mild® procedure alongside vertebral augmentation and basivertebral nerve ablation products, making it the most directly comparable incumbent in Vertos's LSS and interventional pain space.
  • Boston Scientific: Acquired Vertiflex (Superion) to enter the LSS market and has a broader pain and neuromodulation portfolio, making it a key incumbent competing for the same physician customers and LSS patient population.
  • Medtronic: Global spine leader with a comprehensive portfolio of surgical and interventional spine products, competing for hospital and ASC budgets and serving the same pain management and spine surgeon customers as Vertos.
  • Globus Medical: Spine-focused medtech (now combined with NuVasive) with a broad MIS and interventional spine portfolio, competing with Vertos for the same hospital and ambulatory surgery center customers.
  • Abbott: Spinal cord stimulation (Proclaim) and broader neuromodulation portfolio positioned as a downstream therapy for chronic low back and leg pain patients, often competing with or complementing mild® in the same treatment pathway.

Direct peers

  • Vertiflex (now part of Boston Scientific): Developer of the Superion Indirect Decompression System, an interspinous spacer for moderate LSS—historically the most direct procedural alternative to mild® and now commercialized inside Boston Scientific.
  • Relievant Medsystems: Maker of the Intracept procedure for vertebrogenic (basivertebral nerve) pain, an outpatient minimally invasive therapy targeting a closely overlapping LSS-adjacent patient population and physician call point.
  • Spinal Simplicity: Developer of minimally invasive spine devices (including the Minuteman and Liberty products) targeting outpatient treatment of spinal stenosis and adjacent indications—a direct procedural and channel competitor to Vertos.

Emerging players

  • SI-Bone: Specialist in minimally invasive sacroiliac joint fusion (iFuse), competing for the same pain management and interventional spine call point with an outpatient, MIS profile analogous to mild®.
  • Alphatec Spine: Independent spine company focused on MIS and lateral approaches, competing with Vertos for surgeon mindshare and hospital/ASC accounts in the degenerative lumbar and LSS-adjacent segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Vertos Medical social profiles

Digital presence

Vertos Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vertos Medical leadership team

Management profile

Number of profiles

Profiles3 records

Vertos Medical funding detail

Funding detail

Funding overview

Funding rounds14 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vertos Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vertos Medical

What does Vertos Medical do?

Vertos Medical develops and markets the mild® System, a set of minimally invasive medical instruments used to perform the mild® Procedure for treating lumbar spinal stenosis (LSS). The procedure removes small portions of bone and ligament tissue through a small incision to relieve nerve pressure, and is typically delivered by pain management physicians or spine specialists in outpatient settings such as ambulatory surgery centers and office-based labs.

Is Vertos Medical a public or private company?

Vertos Medical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Vertos Medical founded?

Vertos Medical was founded in 2005. It employs 11 to 50 people.

Where is Vertos Medical based?

Vertos Medical is headquartered in Aliso Viejo, United States, in the North America region.

How does Vertos Medical make money?

One revenue line is on record: medical Device Sales - mild® Procedure.

Who are Vertos Medical's main competitors?

Broad incumbents on record are Stryker, Boston Scientific, Medtronic, Globus Medical and Abbott. Direct peers are Vertiflex (now part of Boston Scientific), Relievant Medsystems and Spinal Simplicity. Emerging players are SI-Bone and Alphatec Spine.

Does Vertos Medical have an API?

No public API is recorded for Vertos Medical.

What industry is Vertos Medical in?

Vertos Medical's product category is Minimally Invasive Spine Medical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAKALAM, Pain Management (Spine & Musculoskeletal). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comLeading Companies Fueling Growth and Innovation in the Spinal Surgery Devices and Equipment MarketThe spinal surgery devices and equipment market is forecast to reach $14.3 billion by 2030, growing at a compound annual growth rate of 5.2%, driven by advancements in robotic-assisted surgeries, precision surgical technologies, and outpatient spine surgery centers. In October 2024, Stryker Corporation acquired Vertos Medical Inc. to expand its portfolio with non-surgical solutions for chronic lower back pain and strengthen its presence in ambulatory surgery centers. In August 2024, DePuy Synthes (part of Johnson & Johnson MedTech) introduced the FDA-cleared VELYS Active Robotic-Assisted System, developed with eCential Robotics, for spinal fusion surgeries.KnobbemedicalVertos Medical Latest Acquistion in Stryker's M&A StreakStryker announced the completion of its acquisition of Vertos Medical, a private company specializing in interventional pain management solutions for chronic back pain. This transaction marks Stryker's seventh acquisition in the past year, further expanding its portfolio with technologies such as the minimally invasive mild® procedure. The move is intended to enhance Stryker's non-surgical solutions and broaden its presence in ambulatory surgery centers.YahooStryker's M&A Hot Streak Continues with Vertos Medical BuyStryker completed its acquisition of Vertos Medical, a company specializing in interventional pain management for chronic lower back pain from lumbar spinal stenosis. The deal follows recent acquisitions of NICO, care.ai, and MOLLI Surgical, expanding Stryker's non-surgical interventional solutions. The purchase aims to broaden Stryker's presence in ambulatory surgery centers.Pulse 2.0Stryker To Buy Vertos Medical For Treating Chronic Lower Back PainStryker announced a definitive agreement to acquire Vertos Medical, a privately held company offering a minimally invasive solution for chronic lower back pain from lumbar spinal stenosis. The deal is subject to customary closing conditions, and both companies will continue operating separately until the transaction closes.YahooStryker continues year of spending with Vertos Medical acquisitionStryker agreed to acquire Vertos Medical, a developer of a minimally invasive procedure for lumbar spinal stenosis. The deal's financial terms and completion date were not disclosed, and Stryker said it and Vertos will operate as separate entities. Stryker expects continued M&A activity in the second half of the year.PR NewswireVertos Medical Promotes Two Senior Leaders to Newly Created C-Suite RolesVertos Medical Inc., a medical device company specializing in minimally invasive treatments for lumbar spinal stenosis, has promoted two senior executives—Stephen E. Paul as Chief Commercial Officer and Mehrzad Khakpour, Ph.D. as Chief Technology Officer—to newly created C-suite roles. The promotions follow a recent Series C equity funding round exceeding $26 million and come amid significant company growth, including 348% revenue growth between 2018 and 2021. The company aims to expand nationwide adoption of its proprietary mild® Procedure, which has already treated over 75,000 patients in the United States.Pulse 2.0Vertos Medical: $26 Million Closed To Develop Minimally Invasive Treatments For Lumbar Spinal StenosisVertos Medical has raised $26 million in a Series C equity funding round led by Norwest Venture Partners, with participation from Pitango Venture Capital. The funding will expand patient access to its mild Procedure for lumbar spinal stenosis and support research and development efforts to improve treatments for chronic low back pain. The company has treated over 70,000 patients in the United States, indicating growing demand for its innovative medical solution.Ow.ly Link ShortenerVertos Medical Raises $26M for Minimally Invasive Spinal ProcedureVertos Medical secured $26 million in Series C funding led by Norwest Venture Partners to support its development of minimally invasive devices for lumbar spinal stenosis. The company's flagship product, 'mild', is an image-guided procedure that removes bone and ligament tissue to relieve spinal canal narrowing without requiring general anesthesia or implants. Vertos aims to expand the adoption of this outpatient treatment among physicians as an alternative to conservative care options like epidural steroid injections.FinSMEsVertos Medical Raises $26M in FundingVertos Medical raised $26M in funding led by Norwest Venture Partners, with participation from existing investors. The company will use the funds for research and development of its minimally invasive treatment for lumbar spinal stenosis. Dr. Zack Scott will join the board.